Skip to main content
Livermore
Livermore
ZHEN

OKYO Pharma Ltd

OKYO
Exchange
Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
SEC CIK
0001849296

In the last 90 days, OKYO Pharma Ltd insiders filed 7 open-market purchases and 0 sales; 19 institutions reported holding it in 13F filings for Q2 2026, worth $9.74M in total; no superinvestor holds it.

13F holders, Q2 2023

Institutional positions in OKYO Pharma Ltd as of Jun 30, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works

Institutional holders
2
+1 vs. Q1 2023
Shares held
36.5K
+16.7K (+84.5%) vs. Q1 2023
Total value
$14.1K
−$19.2K (−57.6%) vs. Q1 2023
New holders
2
0 more added
Sold out
1
0 more reduced

Compare with Q1 2023: new holders, sold out and not filed yet

Holders and value by quarter

Institutions reporting OKYO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.

Institutional holdersQ2 2023: 2 institutions
Q1 2021: 0 institutionsQ2 2021: 0 institutionsQ3 2021: 0 institutionsQ4 2021: 0 institutionsQ1 2022: 0 institutionsQ2 2022: 3 institutionsQ3 2022: 1 institutionQ4 2022: 1 institutionQ1 2023: 1 institutionQ2 2023: 2 institutionsQ3 2023: 7 institutionsQ4 2023: 7 institutionsQ1 2024: 6 institutionsQ2 2024: 7 institutionsQ3 2024: 6 institutionsQ4 2024: 7 institutionsQ1 2025: 7 institutionsQ2 2025: 5 institutionsQ3 2025: 8 institutionsQ4 2025: 10 institutionsQ1 2026: 12 institutionsQ2 2026: 19 institutions
Value heldQ2 2023: $14.1K
Q1 2021: $0Q2 2021: $0Q3 2021: $0Q4 2021: $0Q1 2022: $0Q2 2022: $62.0KQ3 2022: $3.00KQ4 2022: $14.4KQ1 2023: $33.3KQ2 2023: $14.1KQ3 2023: $176.0KQ4 2023: $1.51MQ1 2024: $1.36MQ2 2024: $1.21MQ3 2024: $1.02MQ4 2024: $1.18MQ1 2025: $2.63MQ2 2025: $1.48MQ3 2025: $5.14MQ4 2025: $1.15MQ1 2026: $10.3MQ2 2026: $9.74M
Institutions holding OKYO and their total value by quarter
QuarterHoldersValue
Q2 202619$9.74M
Q1 202612$10.3M
Q4 202510$1.15M
Q3 20258$5.14M
Q2 20255$1.48M
Q1 20257$2.63M
Q4 20247$1.18M
Q3 20246$1.02M
Q2 20247$1.21M
Q1 20246$1.36M
Q4 20237$1.51M
Q3 20237$176.0K
Q2 20232$14.1K
Q1 20231$33.3K
Q4 20221$14.4K
Q3 20221$3.00K
Q2 20223$62.0K
Q1 20220$0
Q4 20210$0
Q3 20210$0
Q2 20210$0
Q1 20210$0

Institutions, Q2 2023

Shares, value and share of portfolio for each institution holding OKYO Pharma Ltd; share changes are against Q1 2023.

Institutions holding OKYO in Q2 2023
InstitutionSharesValue% of portfolioChange in sharesAction
HSBC Holdings PLC11,933$13.7K0.00%+11,933New
Atlantic Private Wealth, LLC24,615$4290.00%+24,615New
Goldman Sachs Group Inc0$00.00%−19,807−100.0%Sold out